↓ Skip to main content

Dove Medical Press

A vascular access and midlines program can decrease hospital-acquired central line-associated bloodstream infections and cost to a community-based hospital

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy
1 policy source
twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
51 Mendeley
Title
A vascular access and midlines program can decrease hospital-acquired central line-associated bloodstream infections and cost to a community-based hospital
Published in
Therapeutics and Clinical Risk Management, August 2018
DOI 10.2147/tcrm.s171748
Pubmed ID
Authors

Rahul Pathak, Sumalatha Gangina, Falina Jairam, Kimberly Hinton

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 16%
Student > Master 7 14%
Researcher 6 12%
Other 5 10%
Student > Postgraduate 5 10%
Other 4 8%
Unknown 16 31%
Readers by discipline Count As %
Nursing and Health Professions 22 43%
Medicine and Dentistry 11 22%
Social Sciences 1 2%
Mathematics 1 2%
Unknown 16 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2023.
All research outputs
#5,287,218
of 25,385,509 outputs
Outputs from Therapeutics and Clinical Risk Management
#263
of 1,323 outputs
Outputs of similar age
#93,352
of 341,886 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#7
of 35 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,886 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.